Glioblastoma, Part II: Molecular Targets and Clinical Trials, An Issue of Neurosurgery Clinics of North America: Volume 32-2

This issue of Neurosurgery Clinics, guest edited by Dr. Linda M. Liau, is dedicated to Glioblastoma: Molecular and Clinical Trials. This issue is one of four selected each year by the series consulting editors, Drs. Russell R. Lonser and Daniel K. Resnick. Topics will include-but are not limited to-Pathology & Molecular Markers, Cellular States & Genetic Diversity in Glioblastoma, Mismatch Repair in Glioblastoma Resistance, Genetic Susceptibility in Brain Cancer, Pediatric Gliomas: Molecular Landscape & Emerging Targets, Molecularly Targeted Clinical Trials, Novel Radiation Sensitizers, Immunotherapy Checkpoint Inhibitors, Brain Tumor Vaccines, CAR T Cells, Oncolytic Virotherapy, Targeting Cancer Stem Cells, Therapeutic Delivery to CNS, Theranostics: Dual Modality PET Tracers, and Neuroimaging & Novel Response Assessments.

Product details

• Assisted by: Liau (Editor), Linda M. Liau (Editor), Linda M. (Chair Liau (Editor), Liau Linda M. (Editor)
• Publisher: Elsevier
• Languages: English
• Product format: Hardback
• Released: 30.04.2021
• EAN: 9780323813051
• ISBN: 978-0-323-81305-1
• Dimensions: 178 mm x 254 mm x 15 mm
• Weight: 570 g
• Series: The Clinics: Surgery; The Clinics: Surgery, Volume 3
• Subjects: Natural sciences, medicine, IT, technology > Medicine > Clinical medicine; neurosurgery, MEDICAL / Surgery / Neurosurgery